Exploring Global Regulatory Perspectives and Practical ApplicationsC&R Research hosts its 6th webinar on June 24,“Making Bayesian Work in Clinical Trials: Regulatory Perspectives and Practical Insights.”The webinar explores FDA and EMA regulatory perspectives andpractical applications of Bayesian methods in clinical research.For more details, please refer to the link below.Read the text | Ref: Hankyung

KRW 18.3 Billion in Cumulative orders since Indonesia Branch LaunchC&R Research signed an additional global Phase 3 clinical trial contract worth approximately KRW 5 billion with Daewoong Pharmaceutical,bringing its cumulative global order volume to KRW 18.3 billion based on its multinational clinical trial capabilities centered in Indonesia.Accordingly, the company is expected to further strengthen its position as an “Asian Global CRO” based on the network it has built across Asia.For more details, please refer to the link below.Read the text | Ref: Edaily

Strengthening Clinical Operations in Southeast AsiaC&R Research has entered into strategic partnerships with Vietnamese CROs, VietStar Biomedical Research and Smart Research. Through these collaborations, we aim to strengthen multi-country clinical trial operations in Southeast Asia, enhance local execution capabilities, and expand our clinical competitiveness across Asia.For more details, please refer to the link below.Read the text | Ref: THE BIO

First Domestic Adoption of Taimei AI Agent Secured with 1-year ExclusivityC&R Research has signed a comprehensive agreement with Taimei Technology to drive AI-based clinical innovation.With the first domestic adoption of the Taimei AI Agent and a one-year exclusivity secured,the company is set to advance the implementation of an AI-powered clinical trial operation system.For more details, please refer to the link below.Read the text | Ref: Edaily

   MRD Biomarkers for Tracking Invisible Cancer: Spotlight on FDA Accelerated Approval StrategiesC&R Research host its 5th webinar on April 29 under the theme,'Beyond Response: How MRD is Transforming Cancer Treatment and Drug Development'.The session will highlight the scientific significance of MRDand evolving clinical development strategies aligned with global regulatory standards.For more details, please refer to the link below.Read the text | Ref: Edaily

    Across Korea and Indonesia...Accelerating Global Clinical ExpansionC&R Research has initiated a large-scale Phase 3 MRCT in collaboration with Daewoong Pharmaceutical.Through this study across Korea and Indonesia, C&R Research is accelerating its global expansion.For more details, please refer to the link below.Read the text | Ref: The Yakup News